Current Landscape and Future Directions of Multi-specific Antibodies

Explore the current landscape and future directions of multi-specific antibodies in this 45-minute webinar presented by Dr. Shebna Massey, Associate Product Manager at Sino Biological. Gain insights into the fast-growing market of antibody therapeutics, focusing on bispecific and tetra-specific antibodies. Learn about their enhanced specificity, improved targetability, and efficacy in treating various diseases, from cancer to infectious diseases. Discover recent advancements, preclinical developments, and clinical testing approvals for this promising therapy. Discuss challenges and barriers in advancing multi-specific antibodies and explore current research aimed at overcoming these obstacles. Understand how Sino Biological's products and services support preclinical research in antibody therapy. Earn PACE credits by watching the webinar and following the provided instructions.

Introduction
Overview of Multispecific Antibodies
Advantages of Multispecific Antibodies
Challenges of Multispecific Antibodies
Supporting Multispecific Antibodies
Antibody Development Services
Conclusion
Questions
Current Status
Commercial Pipeline
selectivity of multispecific antibodies
does cob biological develop multispecific antibodies
what services does cob biological offer